Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study.
Gennaro MartucciMarco GianiMatthieu SchmidtKenichi TanakaAli TabatabaiFabio TuzzolinoCara AgerstrandJordi RieraRaj RamananGiacomo GrasselliAli Ait HssainWhitney D GannonSara BuabbasVojka GorjupBrian TrethowanMonica RizzoVito FanelliKyeongman JeonGennaro De PascaleAlain CombesMarco V RanieriThibault DuburcqGiuseppe FotiJuan I ChicoMartin BalikLars Mikael BromanPeter SchellongowskiHergen BuscherRoberto LorussoDaniel BrodieAntonio Arcadipanenull nullPublished in: American journal of respiratory and critical care medicine (2023)
Anticoagulation during VV ECMO was a dynamic process, with frequent stopping in cases of bleeding, and restart according to the clinical picture. Future studies might explore lower aPTT targets to reduce the risk of bleeding.